RSS

Depression

flow.jpg

www.apeloga.se

A clinical study evaluating combined transcranial direct current stimulation (tDCS) and behaviour therapy will take place – and could lead to a new treatment for depression. Read more

News

Flowheadset 1.jpg

www.apeloga.se

Some Harley Street outpatient clinics specialising in delivering mental health support have partnered with medical device company Flow Neuroscience to offer patients a new medically approved brain stimulation headset to treat depression. Read more

News

Flow headset.jpg

www.apeloga.se

Medical device company Flow, creators of a medically approved treatment for depression has raised $1.5 million in an investment round led by Khosla Ventures to tackle mental health challenges. Read more

News

FlowDevice2.jpg

www.apeloga.se

Medical device company Flow has launched a medication-free treatment for depression in the UK. The treatment comprises a brain stimulation headset and a therapy app. Read more

News

P1vital Products (PPL) has, in partnership with Canterbury and Coastal CCG, University of Kent, and the mental health charity MIND, been awarded £815,500 by Innovate UK to advance research to improve the treatment of depression. Read more

News

Drug delivery systems provider Aptar Pharma has announced that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. Read more

News

Scientists from the University of Vermont have found that wearable sensors could help detect anxiety and depression in young children. Read more

News

A new device designed to ‘revolutionise’ depression therapy has received CE mark approval and is now available across Europe. Read more

News